Vous êtes ici

Pharmadrug Inc.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
PHRX
Indice CSE: 
No
Devise: 
CAD

PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. PharmaDrug owns 100% of Pharmadrug Production GmbH (“Pharmadrug Production”), a German medical cannabis distributor, with a Schedule I European Union narcotics license and German EuGMP certification allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the European Union. PharmaDrug owns 100% Sairiyo Therapeutics (“Sairiyo”), a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through clinical trials and the associated regulatory approval process in the US and Europe. Sairiyo is currently developing its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious disease and rare cancers. Sairiyo is also conducting R&D in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also owns 100% of Super Smart, a company building a vertically integrated retail business with the goal to elevate the use of functional mushrooms as natural based medicines.

Pharmadrug Inc. (PHRX)

0.015
0.00 (0.00%)

Pharmadrug Inc. (PHRX)

*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.

Citation

Quantité demandé
4,000 
Cours acheteur
0.015 
Cours vendeur
0.02 
Quantité offerte
773,000 
Volume
53,000 
Dernier prix
0.015 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.015 
Ouverture
0.015 
Day High
0.015 
Day Low
0.015 
Haut 52 semaines
0.055 
Bas 52 semaines
0.005 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Quantité demandé
400,000 
Cours acheteur
0.01 
Cours vendeur
0.02 
Quantité offerte
3,000 
Volume
Dernier prix
0.01 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.01 
Ouverture
0.00 
Day High
0.00 
Day Low
0.00 
Haut 52 semaines
 
Bas 52 semaines
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Citation

Quantité demandé
4,000 
Cours acheteur
0.015 
Cours vendeur
0.02 
Quantité offerte
773,000 
Volume
53,000 
Dernier prix
0.015 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.015 
Ouverture
0.015 
Day High
0.015 
Day Low
0.015 
Haut 52 semaines
0.055 
Bas 52 semaines
0.005 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Quantité demandé
400,000 
Cours acheteur
0.01 
Cours vendeur
0.02 
Quantité offerte
3,000 
Volume
Dernier prix
0.01 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.01 
Ouverture
0.00 
Day High
0.00 
Day Low
0.00 
Haut 52 semaines
 
Bas 52 semaines
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Profondeur de marche par ordre

  • PHRX / Dernière mise à jour: 15:51:59 ET
  • Refresh
  • Info
Courtier Bid Quantité demandé Cours acheteur Cours vendeur Quantité offerte Demandez Broker
Scotia Capital Inc. 4,000 0.015 0.02 72,000 RBC Capital Markets
Desjardins Securities Inc. 79,000 0.01 0.02 20,000 National Bank Financial Inc.
TD Securities Inc. 20,000 0.01 0.02 51,000 TD Securities Inc.
TD Securities Inc. 15,000 0.01 0.02 100,000 TD Securities Inc.
Desjardins Securities Inc. 60,000 0.01 0.02 16,000 TD Securities Inc.
TD Securities Inc. 100,000 0.01 0.02 52,000 BMO Nesbitt Burns Inc.
TD Securities Inc. 40,000 0.01 0.02 16,000 TD Securities Inc.
TD Securities Inc. 20,000 0.01 0.02 8,000 TD Securities Inc.
TD Securities Inc. 50,000 0.01 0.02 20,000 TD Securities Inc.
TD Securities Inc. 500,000 0.01 0.02 6,000 National Bank Financial Inc.
Courtier Bid Quantité demandé Cours acheteur Cours vendeur Quantité offerte Demandez Broker
Anonymous 200,000 0.01 0.02 3,000 Anonymous
Anonymous 200,000 0.01 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0

Profondeur d'affichage de prix

  • PHRX / Dernière mise à jour: 15:51:59 ET
  • Refresh
  • Info
Acheteur Quantité demandé Cours acheteur Cours vendeur Quantité offerte Vendeur
1 4,000 0.015 0.02 773,000 21
33 1,902,000 0.01 0.025 599,000 9
16 1,572,000 0.005 0.03 179,000 6
0 0 0.00 0.035 215,000 7
0 0 0.00 0.04 86,000 4
Acheteur Quantité demandé Cours acheteur Cours vendeur Quantité offerte Vendeur
2 400,000 0.01 0.02 3,000 1
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0

Métiers récents

  • PHRX / Dernière mise à jour: 15:51:40 ET
  • Refresh
  • Info
Date/Heure Prix Modifier Volume Acheteur Vendeur Venue
Mar 14, 19:51 0.015 0.00 6,000 Scotia Capital Inc. Questrade Inc. CSE
Mar 14, 16:53 0.015 0.00 1,000 Scotia Capital Inc. Questrade Inc. CSE
Mar 14, 15:31 0.015 0.00 40,000 Scotia Capital Inc. Scotia Capital Inc. CSE
Mar 14, 13:47 0.015 0.00 6,000 Scotia Capital Inc. National Bank Financial Inc. CSE
Mar 13, 14:02 0.015 0.00 59,000 TD Securities Inc. Scotia Capital Inc. CSE

Information d'entreprise

Addresse
77 King St. West, Suite 2905
Toronto, ON M5K 1H1
Canada
Téléphone
647-202-1824
Fax
416-765-0029
Courriel
info@aurahealthinc.com
URL
http://www.pharmadrug.com
Date d’inscription à la cote
Jeudi, août 16, 2018
Agent de transfert
Capital Transfer Agency

SEDAR Information

Type de dossier Tout News Releases Management's Discussion & Analysis Financial Statements Material Change Report
Délai @count semaine@count mois3 month6 month@count annéeTout le temps

Information d'entreprise

Addresse
77 King St. West, Suite 2905
Toronto, ON M5K 1H1
Canada
Téléphone
647-202-1824
Fax
416-765-0029
Courriel
info@aurahealthinc.com
URL
http://www.pharmadrug.com
Date d’inscription à la cote
Jeudi, août 16, 2018
Agent de transfert
Capital Transfer Agency

Capitalisation

Capitalisation: 
104556647
Réservé à l'émission: 
15240323

Company Officers

Robert Steen, CEO
Kyle Appleby, CFO

Bulletins

20/10/2023

2023-1038 – Consolidation - Pharmadrug Inc. (PHRX)

le 20 octobre/October 2023

Pharmadrug Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every seven (7) pre-consolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 51,518,049 common shares.

The name and symbol will not change.